Jamie Jabalee

8PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 08, 2026
Utility of Early Post-Treatment Circulating Tumor Tissue Modified Viral HPV DNA Testing in HPV-Associated Oropharyngeal Cancer.

|Jan 10, 2026
Resolving Clinically Indeterminate Findings During Anal Cancer Surveillance with TTMV-HPV DNA.

Rafi Kabarriti, Shane Lloyd, James Jabalee

|Jan 25, 2025
Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence.

Rafi Kabarriti, Shane Lloyd, James Jabalee

|Aug 11, 2023
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.

Glenn J Hanna, Scott A Roof, Jamie Jabalee

|Apr 30, 2021
The Role of Extracellular Vesicles in Mediating Resistance to Anticancer Therapies.

Saeideh Maleki, James Jabalee, Cathie Garnis

|Sep 22, 2020
The Role of Cancer-Associated Fibroblasts and Extracellular Vesicles in Tumorigenesis.

Issraa Shoucair, Fernanda Weber Mello, James Jabalee

Pageof 2

Frequent Collaborators

2 joint publications

Rocco Ferrandino

2 joint publications

Marshall R Posner

2 joint publications

Eleni M Rettig

2 joint publications

Scott A Roof